Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 8480832.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In a double-blind, crossover study, 13 fluoxetine-treated patients with obsessive-compulsive disorder were given adjuvant buspirone and placebo for 4 weeks each. There were no significant differences between buspirone and placebo in obsessive-compulsive, depressive, or anxiety symptoms.
Medical subject headings
- Buspirone
- Fluoxetine
- Obsessive-Compulsive Disorder